9th Circ. Won't Rehear Investor Suit Over Arena's Diet Drug
The Ninth Circuit on Tuesday denied Arena Pharmaceuticals' request for a full panel rehearing of its decision that revived a proposed class action alleging the company lied to shareholders that testing...To view the full article, register now.
Already a subscriber? Click here to view full article